Dear Business & Industry Insider,
Women with dense breast tissue face a double whammy when it comes to cancer risk. Not only is dense breast tissue a risk factor for higher cancer incidence, but denser tissue can confound x-ray-based mammography -- both analog and digital. What's a woman to do?
Enter a start-up company from New Zealand called Mātakina Technology. Founded by experts in breast tissue quantification, the company has developed a software algorithm called Volpara that it believes could offer a solution to the breast density dilemma. Learn more in this month's Insider Exclusive by clicking here.
For other recent news in the Business & Industry Digital Community, click on the highlighted stories below:
- Learn about new projections for growth in the European PACS and nuclear medicine markets.
- Find out which firm was selected to start developing a source for medical isotopes in the U.S.
- Find out why a U.S. senator is asking hospitals to report on problems they may be having with their healthcare IT vendors.
- Hear about which two major contrast agent developers received notices from the U.S. Food and Drug Administration regarding their marketing materials for x-ray contrast agents.
